Replicel Life Sciences Inc
XTSX:RP

Watchlist Manager
Replicel Life Sciences Inc Logo
Replicel Life Sciences Inc
XTSX:RP
Watchlist
Price: 0.015 CAD -25%
Market Cap: 954.8k CAD
Have any thoughts about
Replicel Life Sciences Inc?
Write Note

Replicel Life Sciences Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Replicel Life Sciences Inc
Operating Expenses Peer Comparison

Comparables:
ABCL
ARCH
IOT

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Replicel Life Sciences Inc
XTSX:RP
Operating Expenses
-CA$1.7m
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
7%
Abcellera Biologics Inc
NASDAQ:ABCL
Operating Expenses
-$275.2m
CAGR 3-Years
-53%
CAGR 5-Years
-96%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Operating Expenses
-CA$10m
CAGR 3-Years
-1%
CAGR 5-Years
-39%
CAGR 10-Years
-39%
Innovotech Inc
XTSX:IOT
Operating Expenses
-CA$1.4m
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-2%

See Also

What is Replicel Life Sciences Inc's Operating Expenses?
Operating Expenses
-1.7m CAD

Based on the financial report for Sep 30, 2023, Replicel Life Sciences Inc's Operating Expenses amounts to -1.7m CAD.

What is Replicel Life Sciences Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
7%

Over the last year, the Operating Expenses growth was 6%. The average annual Operating Expenses growth rates for Replicel Life Sciences Inc have been 11% over the past three years , 7% over the past five years , and 7% over the past ten years .

Back to Top